Topics

Fagron to pay $22.5 million to settle U.S. allegations over inflated drug prices

09:32 EST 7 Nov 2019 | Reuters

Pharmaceutical supplier Fagron Holding USA LLC will pay $22.5 million to resolve allegations that its subsidiaries inflated average wholesale prices for compound drug ingredients and submitted fraudulent claims to federal healthcare programs, the U.S...

Original Article: Fagron to pay $22.5 million to settle U.S. allegations over inflated drug prices

NEXT ARTICLE

More From BioPortfolio on "Fagron to pay $22.5 million to settle U.S. allegations over inflated drug prices"

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...